Study Regarding the Incidence of Anti-platelet Factor 4-antibodies in Patients Aged 18 to 60 Years With Spontaneous or Infection- or Vaccine-associated or Recurrent Venous and/or Arterial Thrombosis

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

July 31, 2026

Study Completion Date

January 31, 2027

Conditions
Arterial or Venous Thrombosis
Interventions
DIAGNOSTIC_TEST

Determination of anti-platelet factor 4 antibodies in the blood

"The anti-platelet factor 4 antibodies in the blood are determined using latex agglutination and the chemiluminescence method in the coagulation laboratory of the CCB MVZ laboratory. In addition, the platelet factor 4-induced platelet activation test (PIPA test) and the heparin-induced platelet activation test (HIPA test) as well as an ELISA-based platelet factor 4 IgG antibody test (Prof. Greinacher, Greifswald University Hospital) will be performed as part of the routine work up.~In addition a new assay for heparin-independent anti-PF4 antibody detection provided by the company Werfen using chemiluminescence will be performed."

Trial Locations (2)

10117

NOT_YET_RECRUITING

Deutsches Herzzentrum der Charite (DHZC), Berlin

60389

RECRUITING

Cardioangiologisches Zentrum Bethanien (CCB), Frankfurt am Main

All Listed Sponsors
lead

Cardioangiologisches Centrum Bethanien

OTHER